YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
This article first appeared on GuruFocus. A Deep Dive into Terumo Corp's Upcoming Dividend and Financial Health Terumo Corp (TRUMF) recently announced a total dividend of $0.11 per share, with the ex-dividend date set for September 29, 202…
Company Logo The global interventional cardiology devices market is forecast to grow from USD 31.12 billion in 2026 to USD 42.39 billion by 2031, at a 6.4% CAGR. Growth is driven by rising cardiovascular disease, aging populations, demand…
Company Logo The global vascular access device market is projected to grow from USD 6.27 billion in 2026 to USD 8.68 billion by 2031, at a 6.7% CAGR. Growth is driven by rising cancer, cardiovascular and kidney disease cases, increased IV…
ORGANOX LIMITED National Institute for Health and Care Excellence (NICE) guidance supports wider patient access to life-saving liver transplantation through routine adoption of machine perfusion technologies across England OXFORD, United K…
This article first appeared on GuruFocus. Release Date: August 07, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record high quarterly revenue of JPY311.8 billion,…
* Terumo press release [https://www.terumo.com/system/files/document/2026-08/FinancialResults_27Q1_E.pdf] (TRUMF [https://seekingalpha.com/symbol/TRUMF]): Q1 GAAP EPS of ¥47.73. * Revenue of ¥311.81B (+19.9% Y/Y). [https://static.seekingal…
Company Logo Disposables lead the product segment, while plasmapheresis holds the largest procedure share. North America dominates the market. Key players include Terumo, Fresenius, Haemonetics, BD and B. Braun. Apheresis MarketApheresis M…
For Immediate Release Chicago, IL – July 21, 2026 – Today, Zacks Equity Research discusses Terumo TRUMY, QuidelOrtho QDEL, Lumexa Imaging Holdings, Inc. LMRI and Brainsway BWAY. Industry: Medical Products Link: https://www.zacks.com/commen…
The Zacks Medical – Products industry is navigating an uneven operating environment where macroeconomic headwinds are colliding with strong structural healthcare demand. Rising tariffs, persistent inflation in electronic components, freigh…
Published in the International Journal of Surgery, globally ranked in the top three among surgery journals, the article highlights strong clinical outcomes with ProSense® cryoablation and describes thermal ablation as a "beacon of hope for…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Terumo (TSE:4543) is back in focus after reporting full year result…
Terumo Corporation has reported past full-year results for the 12 months to March 31, 2026, with sales rising to ¥1,131.88 billion and net income reaching ¥135.91 billion, alongside higher basic and diluted earnings per share from continui…
Asian stock markets sagged on Monday, as the Strait of Hormuz remained closed to oil-tanker traffic, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
ORGANOX LIMITED OrganOx enters next phase of growth for continued global expansion and access to life-saving technology OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo…
Company Logo Japan's regenerative medicine market offers opportunities driven by an aging population, progressive regulations, and demand for novel therapies targeting chronic and cosmetic conditions. Innovations in stem cell and gene-edit…
Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Cardiogenic Shock Market: 2026 Edition" has been added to ResearchAndMarkets.com's offering. The global cardiogenic shock market value in 2024 stood at US$3.57 billion, and is projected to reac…
Company Logo The catheter market is poised for significant growth due to rising chronic disease prevalence, increased minimally invasive procedures, and enhanced healthcare access in emerging regions. Opportunities lie in product innovatio…
Company Logo Drug-Eluting Stents MarketDrug-Eluting Stents Market·GlobeNewswire Inc. Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and…
NORTHAMPTON, MA / ACCESS Newswire / April 15, 2026 / The Healthcare Plastics Recycling Council (HPRC) is pleased to welcome Terumo Corporation, a global medical technology company that develops, manufactures, and distributes medical device…
OXFORD, England and STAMFORD, Conn., April 14, 2026 /PRNewswire/ -- Caristo Diagnostics, a University of Oxford spinout and a global leader in AI technology for cardiovascular disease, today announced the appointment of Board Member Stephe…
OXFORD, England and STAMFORD, Conn., April 14, 2026 /PRNewswire/ -- Caristo Diagnostics, a University of Oxford spinout and a global leader in AI technology for cardiovascular disease, today announced the appointment of Board Member Stephe…
Femasys Inc. ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwid…
In March 2026, Terumo Corporation filed a shelf registration for up to ¥200 billion in bonds and, a few days earlier, Tata Elxsi announced the opening of the Terumo–Tata Elxsi Offshore Development Center to support Terumo’s cardiac and vas…
PUNE, India, March 19, 2026 /PRNewswire/ -- Tata Elxsi, a global leader in design and technology services, and Terumo Corporation, a global medical innovation company, today inaugurated the 'Terumo–Tata Elxsi Offshore Development Center'.…
Orchestra BioMed Holdings, Inc. $106.5 million cash position as of December 31, 2025 to be further enhanced by $35 million expected from Medtronic and Ligand in Q2 2026 from previously announced transactions, as well as Haemonetics’ Vivasu…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Intravenous Infusion Pump Market size & share revenue was valued at approximately USD…
A collaborative integration model to enable practical, scalable cell and gene therapy delivery. SINGAPORE, March 5, 2026 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) today announced the launch of its new C> Ecosystem B…
Q-Sera Pty Ltd MELBOURNE, Australia , Feb. 19, 2026 (GLOBE NEWSWIRE) -- Q-Sera Pty Ltd, an Australian venture-backed company, today announced the first product launch of its patented evacuated blood collection technology, with the launch b…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Terumo (TSE:4543) reported record-high revenue and profit for its third quarter. North American d…
This article first appeared on GuruFocus. Release Date: February 13, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Terumo Corp (TRUMF) reported record-high revenue…
* Terumo press release [https://www.terumo.com/system/files/document/2026-02/Presentation_02_26Q3_E.pdf] (TRUMF [https://seekingalpha.com/symbol/TRUMF]): Q3 * Revenue of ¥296.6B (+12.5% Y/Y). * Adjusted operating profit of ¥59.1B. MORE ON…
- New, retractable safety hypodermic line offers enhanced safety, reliability and ease of use while minimizing patient discomfort* - SOMERSET, N.J., Jan. 6, 2026 /PRNewswire/ -- Terumo Medical Corporation, a wholly-owned subsidiary of Teru…
Santersus AG Announces Advancement of NucleoCapture into Pivotal Clinical Development strengthened by Strategic Collaboration with Terumo ZURICH, SWITZERLAND / ACCESS Newswire / December 1, 2025 / Santersus AG today announced the successfu…
Terumo (TSE:4543) has recently caught the attention of investors following a sustained share price decline over the past month, with the stock down nearly 5% and extending to a 14% drop over the past 3 months. This pullback provides an int…
Asian stock markets were mixed on the high-side Thursday, as the US government shutdown ended, the y PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Orchestra BioMed Holdings, Inc. Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 million in committed capital from Medt…